Clinical Trial Update: Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC [Phase 3]

View source ↗

Summary

ClinicalTrials.gov entry updates a Phase 3 safety and immunogenicity trial of the MVA-BN mpox vaccine in the Democratic Republic of Congo, noting the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monkeypox

Drugs mentioned

• MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: Jean-Pierre Van geertruyden | Conditions: Neonate, Maternal Transmission | Phase 3 | Status: ACTIVE_NOT_RECRUITING